Abstract:Background Intensity modulated brachytherapy based on partially shielded intracavitary and interstitial applicators is possible with a cost‐effective 169Yb production method. 169Yb is a traditionally expensive isotope suitable for this purpose, with an average γ‐ray energy of 93 keV. Re‐activating a single 169Yb source multiple times in a nuclear reactor between clinical uses was shown to theoretically reduce cost by approximately 75% relative to conventional single‐activation sources. With re‐activation, substantial spatiotemporal variation in isotopic source composition is expected between activations via 168Yb burnup and 169Yb decay, resulting in time dependent neutron transmission, precursor usage, and reactor time needed per re‐activation. Purpose To introduce a generalized model of radioactive source production that accounts for spatiotemporal variation in isotopic source composition to improve the efficiency estimate of the 169Yb production process, with and without re‐activation. Methods and Materials A time‐dependent thermal neutron transport, isotope transmutation, and decay model was developed. Thermal neutron flux within partitioned sub‐volumes of a cylindrical active source was calculated by raytracing through the spatiotemporal dependent isotopic composition throughout the source, accounting for thermal neutron attenuation along each ray. The model was benchmarked, generalized, and applied to a variety of active source dimensions with radii ranging from 0.4 to 1.0 mm, lengths from 2.5 to 10.5 mm, and volumes from 0.31 to 7.85 mm3, at thermal neutron fluxes from 1 × 1014 to 1 × 1015 n cm−2 s−1. The 168Yb‐Yb2O3 density was 8.5 g cm−3 with 82% 168Yb‐enrichment. As an example, a reference re‐activatable 169Yb active source (RRS) constructed of 82%‐enriched 168Yb‐Yb2O3 precursor was modeled, with 0.6 mm diameter, 10.5 mm length, 3 mm3 volume, 8.5 g cm−3 density, and a thermal neutron activation flux of 4 × 1014 neutrons cm‐2 s‐1. Results The average clinical 169Yb activity for a 0.99 versus 0.31 mm3 source dropped from 20.1 to 7.5 Ci for a 4 × 1014 n cm‐2 s‐1 activation flux and from 20.9 to 8.7 Ci for a 1 × 1015 n cm‐2 s‐1 activation flux. For thermal neutron fluxes ≥2 × 1014 n cm‐2 s‐1, total precursor and reactor time per clinic‐year were maximized at a source volume of 0.99 mm3 and reached a near minimum at 3 mm3. When the spatiotemporal isotopic composition effect was accounted for, average thermal neutron transmission increased over RRS lifetime from 23.6% to 55.9%. A 28% reduction (42.5 days to 30.6 days) in the reactor time needed per clinic‐year for the RRS is predicted relative to a model that does not account for spatiotemporal isotopic composition effects. Conclusions Accounting for spatiotemporal isotopic composition effects within the RRS results in a 28% reduction in the reactor time per clinic‐year relative to the case in which such changes are not accounted for. Smaller volume sources had a disadvantage in that average clinical 169Yb activity decreased substantially below 20 Ci for source volumes under 1 mm3. Increasing source volume above 3 mm3 adds little value in precursor and reactor time savings and has a geometric disadvantage.

Rapid separation, purification of 90Sr and feasibility studies for the preparation of 90Y resin microsphere brachytherapy source from FBTR irradiated fuel dissolver solution

Crown Ether–ionic Liquid-Based Extraction Chromatographic Resin for Separation of 90 Y from 90 Sr

Efficient separation of radium from natural thorium using a mesoporous silica-supported composite resin with sulfonic acid groups for the acquisition of targeted α-nuclides 212Pb

Radiochemistry, pre-clinical studies and first clinical investigation of 90Y-labeled hydroxyapatite (HA) particles prepared utilizing 90Y produced by (n,γ) route

A quick liquid scintillation counting technique for analysis of ⁹⁰Sr in environmental samples

Solid-phase isotope harvesting of 88Zr from a radioactive ion beam facility

Pressed Solid Target Production of 89Zr and its Application for Antibody Labelling

Sorption Characteristics and Chromatographic Separation of 90Y3+ from 90Sr2+ from Aqueous Media by Chelex-100 (Anion Ion Exchange) Packed Column

Method and mechanism for efficient radium isolation from bulk thorium based on anion exchange

Separation of lanthanum, hafnium, barium and radiotracers yttrium-88 and barium-133 using crystalline zirconium phosphate and phosphonate compounds as prospective materials for a Ra-223 radioisotope generator

Semi-Permanent Mass Production of Ac-225 for Cancer Therapy by the (3n,x) Reaction in Pressurized Water Reactor

The production and separation of 161Tb with high specific activity at the University of Utah

Alpha-hydroxyisobutyric acid-assisted solid-liquid chromatography for the separation of lutetium-177 from neutron-irradiated natural ytterbium

Optimization of Deuteron Irradiation of 176Yb for Producing 177Lu of High Specific Activity Exceeding 3000 GBq/mg

A new strategy for facile and rapid separation of astatine-211 from nitric acid medium

Rapid, One‐step, High Yielding 18f‐labeling of an Aryltrifluoroborate Bioconjugate by Isotope Exchange at Very High Specific Activity

Determination of 90Sr in highly radioactive aqueous samples via conversion to a kinetically stable 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid complex followed by concentration–separation–fractionation based on capillary electrophoresis–liquid scintillation

Isolation of 212Pb from natural thorium for targeted alpha-therapy

A re‐activation model for 169Yb intensity modulated brachytherapy sources accounting for spatiotemporal isotopic composition

Modified 2-Window Approach for Rapid Determination of 90sr and 90Y at Low Quench Level Using Liquid Scintillation Counting

Simultaneous Separation of Protactinium-230 and Uranium-230 Isotopes from a Proton-Irradiated Thorium Matrix